- Mukesh Buch
- 03 May, 2018
- New York City
Ball Corp reported better-than-expected first-quarter results. Becton, Dickinson net swung to a loss but revenues surged 42%. Cigna lifted fiscal outlook. Cardinal Health net plunged and lowered fiscal earnings outlook. HCP net tumbled. New York Times profit soared 66%.
- Sarla Buch
- 03 May, 2018
- New York City
Arkema profit and revenues surged. Aeroports de Paris profit soared on strong traffic and passenger numbers. Bayer said profit was hurts by negative currency effects. Legrand profit surged on new products.
- Mukesh Buch
- 02 May, 2018
- New York City
Apple iPhone sales jumped and the device maker announced $100 billion stock buyback. AmerisourceBergen revenues exceeded estimate. CVS Health prescription drug sales surged. MasterCard profit soared on higher consumer spending.
- Sarla Buch
- 02 May, 2018
- New York City
bet-at-home profit surged after registered customers jumped. GN Store Nord reaffirmed fiscal revenue forecast and plans to buy back share of up to 1 billion kronor. Inmarsat surged after net swung to profit. Telefonica said net loss in the first-quarter narrowed on flat revenues.
- Mukesh Buch
- 01 May, 2018
- New York City
Aetna net swung to profit. American Tower lowered fiscal outlook. Archer-Daniels net and revenues jumped. Cummins net plunged but revenues surged. Ecolab net fell. Merck net tumbled 54%. Pfizer profit surged but revenues disappointed.
- Sarla Buch
- 01 May, 2018
- New York City
BP profits jumped on higher oil prices and production. Carlsberg lifted profit forecast despite revenues declined. DS Smith said paper volume growth improved in the year. Just Eat reaffirmed fiscal 2018 revenues growth forecast. RPS Group stock soared.
- Mukesh Buch
- 30 Apr, 2018
- New York City
Allergan lifted fiscal outlook after net loss narrowed. CNA had strong start in 2018. Mercury General net swung to a loss on weak revenues. Loews profit fell but revenues soared. McDonald''''s net surged. T-Mobile US and Sprint are in $27 B merger agreement.
- Sarla Buch
- 30 Apr, 2018
- New York City
Accor is in preliminary merger talk with Switzerland-based Movenpick Hotels. Airbus profit plunged 31% on fewer deliveries. Deutsche Bank reported weak-than-expected results. Sainsbury profit declined 10% and the retailer agreed to acquire controlling interest in Asda.
- Mukesh Buch
- 27 Apr, 2018
- New York City
Colgate-Palmolive net soared on improved pricing. Dover formally approved separation of Apergy Corporation. Exxon Mobil profit and revenues soared. Intel lifted revenues forecast and the chipmaker reported a profit surge. Moody
- Sarla Buch
- 27 Apr, 2018
- New York City
Amundi profit soared as net assets under management jumped on the rising inflow. Renault revenues edged up despite sales decline in Asia and Middle East. Sanofi profit tumbled 82% and drug-maker plans to buy back as much as
- Mukesh Buch
- 26 Apr, 2018
- New York City
AbbVie plans to buy back up to $7.5 billion of stocks. Bristol-Myers net declined but revenues jumped. ConocoPhillips profit plunged despite higher oil prices. PepsiCo beats profit and sales expectations.
- Sarla Buch
- 26 Apr, 2018
- New York City
Barclays net swing to a loss and the bank led investor group agreed to buy
- Mukesh Buch
- 25 Apr, 2018
- New York City
Anthem net jumped on lower medical expenses. Boeing lifted forecast on higher defense and aviation revenues. General Dynamics delivered solid first-quarter results. Nasdaq lowered its full-year operating expenses guidance. Twitter first quarter swung to profit.
- Sarla Buch
- 25 Apr, 2018
- New York City
Atos revenues jumped and the software company signed a partnership with Google. Credit Suisse reported stronger-than-expected results. Trivago net swung to loss on higher advertising spending. Zodiac Aerospace revenues declined 12.4%.
- Mukesh Buch
- 24 Apr, 2018
- New York City
Biogen net soared 57% on 11% jump in revenues. Caterpillar profit jumped on strong demand. Coca-Cola profit jumped on lower cost but sales declined 16%. Eli Lilly lifted fiscal outlook on higher sales of diabetes and cancer drugs.